A unicorn is a privately held, venture-backed startup with a reported valuation of $1 billion or more. Coined in 2013, the ...

Our country did not cede the nuclear race to the Soviet Union, and we cannot cede the biotechnology race to China now.

Despite some wincing sound and production design, Yeon Sang-ho fails to deliver the highs of his best zombie projects.

When Daniel Haders, Ph.D., was working in venture capital, he was on the hunt for an AI-driven drug discovery company that ...

If Biogen has shown that tau can impact cognition, Denali’s technology—validated with an FDA approval in Hunter ...

CNS Pharmaceuticals (NASDAQ:CNSP) is back on every biotech watchlist after a 242.36% one-week ramp tied to its Berubicin ...

CREATE Medicines has a new name, an expanded pipeline, and now fresh funding to propel the company’s first CAR-T candidates ...

Shares of REGENXBIO declined 37% on a mixed data readout and other updates from the company's first quarter earnings call ...

The startup was cofounded by noted Pulitzer Prize-winning writer and oncologist Siddhartha Mukherjee to develop better CAR-T ...

There is a moment, somewhere around the second or third week of the Rady Action Project, when students stop treating it like ...

Operator: Greetings, and welcome to the PDS Biotech First Quarter 2026 Earnings Conference Call. [Operator Instructions] It ...

Regenxbio’s gene therapy for Duchenne muscular dystrophy has smashed the primary endpoint of its pivotal trial, securing a ...